CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.853
EU - Europa 3.491
AS - Asia 2.682
SA - Sud America 351
Continente sconosciuto - Info sul continente non disponibili 139
AF - Africa 89
OC - Oceania 9
Totale 10.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.757
RU - Federazione Russa 1.510
SG - Singapore 1.067
CN - Cina 795
GB - Regno Unito 515
IT - Italia 379
BR - Brasile 262
HK - Hong Kong 236
DE - Germania 234
VN - Vietnam 221
FR - Francia 209
IE - Irlanda 190
SE - Svezia 169
KR - Corea 83
FI - Finlandia 82
BD - Bangladesh 64
CA - Canada 52
IN - India 49
UA - Ucraina 48
JP - Giappone 44
AR - Argentina 35
NL - Olanda 34
MX - Messico 25
TR - Turchia 21
PL - Polonia 20
NG - Nigeria 19
ID - Indonesia 18
ES - Italia 16
BE - Belgio 15
IQ - Iraq 12
ZA - Sudafrica 12
DZ - Algeria 11
TG - Togo 11
EC - Ecuador 10
AT - Austria 9
CO - Colombia 9
SA - Arabia Saudita 9
AU - Australia 8
BJ - Benin 8
CL - Cile 8
PE - Perù 8
PY - Paraguay 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
MA - Marocco 7
AL - Albania 6
JM - Giamaica 6
KE - Kenya 6
PH - Filippine 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
AZ - Azerbaigian 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
PK - Pakistan 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
LV - Lettonia 3
UG - Uganda 3
BG - Bulgaria 2
DK - Danimarca 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
GY - Guiana 1
IS - Islanda 1
Totale 10.465
Salva come PNG Salva come JPEG
Città #
Singapore 538
Moscow 515
Ashburn 511
Southend 438
Chandler 418
San Jose 353
Dallas 339
Hong Kong 227
Council Bluffs 195
Dublin 186
Verona 182
Beijing 178
Jacksonville 153
The Dalles 143
Woodbridge 111
Ho Chi Minh City 79
Munich 73
Los Angeles 71
Lawrence 65
Princeton 65
Houston 62
New York 61
Jinan 55
Hanoi 52
Redmond 49
Wilmington 48
Nanjing 43
Santa Clara 43
Helsinki 40
Shenyang 39
São Paulo 35
Tokyo 35
Redondo Beach 34
Buffalo 31
Columbus 30
Orem 30
Tianjin 29
Ann Arbor 24
Haikou 24
Hangzhou 23
Redwood City 23
Frankfurt am Main 22
Milan 21
Seattle 21
Changsha 19
Hebei 19
Montreal 19
Ningbo 19
Sindelfingen 19
London 18
Nanchang 18
Turku 18
Abuja 17
Brooklyn 17
Toronto 17
Washington 17
Falkenstein 16
Warsaw 16
Atlanta 15
Brussels 15
Denver 15
Rio de Janeiro 15
Amsterdam 14
Chennai 14
Nuremberg 13
Zhengzhou 13
Chicago 12
Fairfield 12
Lomé 11
Mexico City 11
Norwalk 11
Taiyuan 11
Taizhou 11
Fuzhou 10
Haiphong 10
Paris 10
San Francisco 10
Belo Horizonte 9
Jakarta 9
Johannesburg 9
Lancaster 9
Lappeenranta 9
Mumbai 9
Stockholm 9
Cotonou 8
Falls Church 8
Genoa 8
Miami 8
Phoenix 8
Tashkent 8
Baghdad 7
Guangzhou 7
Istanbul 7
Manchester 7
Poplar 7
Ankara 6
Boston 6
Curitiba 6
Des Moines 6
Dongguan 6
Totale 6.372
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 256
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 235
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 222
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 220
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 219
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 194
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 190
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 186
Results of a surveillance protocol for pancreatic BD-IPMNs 186
An unforeseeable adverse event during ERCP 183
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 182
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 179
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 178
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 176
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 176
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 171
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 163
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 163
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 163
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 160
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 159
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 157
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 156
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 154
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 153
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 152
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 152
Pancreatic Adenocarcinoma 149
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 147
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 147
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 146
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 142
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 141
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 139
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 138
Defining the practice of distal pancreatectomy around the world 138
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 136
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 135
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 135
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 134
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 131
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 130
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 128
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 128
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 126
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 126
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 122
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 118
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 117
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 113
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 112
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 111
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 109
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 106
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 105
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 100
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 99
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 98
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 97
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 96
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 95
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 95
Surgical experience and the practice of pancreatoduodenectomy 92
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 91
Response to: Managing the High-risk Pancreatic Anastomosis 90
Intraductal Papillary Mucinous Neoplasm Around the World 89
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 89
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 87
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 84
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 81
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 81
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 80
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 80
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 79
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 74
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 72
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 72
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 69
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 67
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 63
Totale 10.614
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.944
article - articoli 38.673
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 797
patent - brevetti 0
selected - selezionate 0
volume - volumi 474
Totale 79.888
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022414 0 120 10 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20264.990 365 218 343 742 1.304 321 447 278 386 307 87 192
2026/2027189 55 134 0 0 0 0 0 0 0 0 0 0
Totale 10.614